These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34998797)

  • 1. Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.
    Kamble N; Bhattacharya A; Hegde S; Vidya N; Gothwal M; Yadav R; Pal PK
    Behav Brain Res; 2022 Mar; 422():113733. PubMed ID: 34998797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical excitability changes in patients of vascular parkinsonism with cognitive impairment.
    Agrawal A; Bhattacharya A; Kamble N; Mailankody P; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2023 Nov; 116():105869. PubMed ID: 37783026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal Intracortical Functions in Parkinson's Disease with Rapid Eye Movement Sleep Behaviour Disorder.
    Bhattacharya A; Kamble N; Yadav R; Stezin A; Pal PK
    Can J Neurol Sci; 2022 Sep; 49(5):672-677. PubMed ID: 34470683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease.
    Cholerton B; Johnson CO; Fish B; Quinn JF; Chung KA; Peterson-Hiller AL; Rosenthal LS; Dawson TM; Albert MS; Hu SC; Mata IF; Leverenz JB; Poston KL; Montine TJ; Zabetian CP; Edwards KL
    Parkinsonism Relat Disord; 2018 May; 50():29-36. PubMed ID: 29478836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Cognitive-Driven Performance-Based Activities of Daily Living Dysfunction in Parkinson's Disease.
    Sulzer P; Bäumer A; Hoang HG; Becker S; Lönneker HD; Graessel E; Liepelt-Scarfone I
    J Int Neuropsychol Soc; 2020 Apr; 26(4):430-440. PubMed ID: 31822319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
    Padovani A; Benussi A; Cantoni V; Dell'Era V; Cotelli MS; Caratozzolo S; Turrone R; Rozzini L; Alberici A; Altomare D; Depari A; Flammini A; Frisoni GB; Borroni B
    J Alzheimers Dis; 2018; 65(1):221-230. PubMed ID: 30010131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anosognosia for cognitive and behavioral symptoms in Parkinson's disease with mild dementia and mild cognitive impairment: Frequency and neuropsychological/neuropsychiatric correlates.
    Orfei MD; Assogna F; Pellicano C; Pontieri FE; Caltagirone C; Pierantozzi M; Stefani A; Spalletta G
    Parkinsonism Relat Disord; 2018 Sep; 54():62-67. PubMed ID: 29709507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Italian version of the Parkinson's Disease- Cognitive Functional Rating Scale.
    Garon M; Weis L; Siquier A; Fiorenzato E; Pistonesi F; Cianci V; Canesi M; Pesce F; Reali E; Pozzi B; Isaias IU; Siri C; Santangelo G; Cuoco S; Barone P; Kulisevsky J; Antonini A; Biundo R
    J Neural Transm (Vienna); 2024 Apr; 131(4):305-314. PubMed ID: 38280057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive Function and Quality of Life in Parkinson's Disease: A Cross-Sectional Study.
    Tang Y; Liang X; Han L; Peng F; Shen B; Yu H; Shen Y; Shen C; Yu J; Wang J
    J Parkinsons Dis; 2020; 10(3):1209-1216. PubMed ID: 32568115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are there differences in cortical excitability between akinetic-rigid and tremor-dominant subtypes of Parkinson's disease?
    Khedr EM; Lefaucheur JP; Hasan AM; Osama K
    Neurophysiol Clin; 2021 Oct; 51(5):443-453. PubMed ID: 34588134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling Parkinson's disease cognitive phenotypes via resting-state magnetoencephalography.
    Simon OB; Rojas DC; Ghosh D; Yang X; Rogers SE; Martin CS; Holden SK; Kluger BM; Buard I
    J Neurophysiol; 2022 Jan; 127(1):279-289. PubMed ID: 34936515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.
    Chung SJ; Yoo HS; Lee YH; Lee HS; Ye BS; Sohn YH; Kwon H; Lee PH
    Hum Brain Mapp; 2019 Sep; 40(13):3784-3794. PubMed ID: 31090134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased facilitation of the primary motor cortex in de novo Parkinson's disease.
    Shirota Y; Ohminami S; Tsutsumi R; Terao Y; Ugawa Y; Tsuji S; Hanajima R
    Parkinsonism Relat Disord; 2019 Sep; 66():125-129. PubMed ID: 31327628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease.
    Liang K; Li X; Guo Q; Ma J; Yang H; Fan Y; Yang D; Shi X; She Z; Qi X; Gu Q; Chen S; Zheng J; Li D
    Neurobiol Dis; 2024 Jan; 190():106379. PubMed ID: 38104911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease progression in Parkinson's disease patients with mild cognitive impairment: 5-year longitudinal study from the early Parkinson's disease longitudinal Singapore (PALS) cohort.
    Deng X; Saffari SE; Xiao B; Ng SYE; Chia N; Choi X; Heng DL; Xu Z; Tay KY; Au WL; Tan EK; Tan LC
    Aging (Albany NY); 2024 Aug; 16(15):11491-11500. PubMed ID: 39137312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.
    Liu H; Deng B; Xie F; Yang X; Xie Z; Chen Y; Yang Z; Huang X; Zhu S; Wang Q
    Ann Clin Transl Neurol; 2021 Sep; 8(9):1917-1934. PubMed ID: 34310081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain degeneration in Parkinson's disease patients with cognitive decline: a coordinate-based meta-analysis.
    Mihaescu AS; Masellis M; Graff-Guerrero A; Kim J; Criaud M; Cho SS; Ghadery C; Valli M; Strafella AP
    Brain Imaging Behav; 2019 Aug; 13(4):1021-1034. PubMed ID: 29971686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease.
    Tang Y; Ge J; Liu F; Wu P; Guo S; Liu Z; Wang Y; Wang Y; Ding Z; Wu J; Zuo C; Wang J
    PLoS One; 2016; 11(4):e0152716. PubMed ID: 27064684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
    Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
    J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.